Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Now accepting nominations for the Fierce Innovation Awards - Submit your application today
Financials
Pharma
BridgeBio’s Attruby cruises toward blockbuster land
As Alnylam’s Amvuttra sales disappointed, revenue from BridgeBio’s rival ATTR drug Attruby came above analysts’ expectations.
Angus Liu
Aug 11, 2026 11:22am
Sarepta's new CEO faces critical tests to prove growth
Aug 6, 2026 11:15am
Narcan maker Emergent axes top R&D post in sweeping restructuring
Aug 5, 2026 8:16pm
Amid struggles of Lilly's Foundayo, injectables still on a roll
Aug 5, 2026 11:42am
Novo CEO stands firm on guidance amid Wegovy pill sales onslaught
Aug 5, 2026 11:20am
Gilead's Yeztugo faces growth outlook questions
Aug 5, 2026 10:44am
